{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:56:13Z","timestamp":1788900973684,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jjcc.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T18:31:04Z","timestamp":1593887464000},"page":"487-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study"],"prefix":"10.1016","volume":"76","author":[{"given":"Shigemasa","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2020.06.006_bib0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013543","article-title":"Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants","volume":"8","author":"Hu","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00325481.2019.1607414","article-title":"The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease","volume":"131","author":"Nelson","year":"2019","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of diabetic dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1253\/circj.CJ-13-1025","article-title":"High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis","volume":"77","author":"Annema","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5650\/jos.ess16020","article-title":"Recent advances in analytical methods on lipoprotein subclasses: calculation of particle numbers from lipid levels by gel permeation HPLC using \"spherical particle model\"","volume":"65","author":"Okazaki","year":"2016","journal-title":"J Oleo Sci"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190875","article-title":"Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency","volume":"13","author":"Okada","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.atherosclerosis.2013.09.008","article-title":"Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women","volume":"231","author":"Furusyo","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0050","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1253\/circj.CJ-12-1401","article-title":"Highly purified eicosapentaenoic acid may increase low-density lipoprotein particle size by improving triglyceride metabolism in patients with hypertriglyceridemia","volume":"77","author":"Tani","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacl.2012.07.001","article-title":"Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)","volume":"6","author":"Bays","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/70.5.817","article-title":"Dietary fish as a major component of a weight loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects","volume":"70","author":"Mori","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0065","first-page":"19","article-title":"Fish, fish oils and cardioprotection: promise or fish tale?","volume":"22","author":"Goel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0070","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.atherosclerosis.2011.09.010","article-title":"Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study","volume":"219","author":"Bogl","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0075","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCULATIONAHA.113.002683","article-title":"Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease","volume":"128","author":"Kingwell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101099","article-title":"The role of omega-3 fatty acids in reverse cholesterol transport: a review","volume":"9","author":"Pizzini","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.5876","article-title":"Relationships between plasma fatty acid composition and coronary artery disease","volume":"18","author":"Itakura","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40256-016-0195-y","article-title":"Impact of adding eicosapentaenoic acid to statin therapy on plasma pentraxin 3 level in patients with stable coronary artery disease: a 6-month, randomized controlled study","volume":"17","author":"Tani","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0095","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0735-1097(01)01682-5","article-title":"AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"38","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0100","first-page":"371","article-title":"A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity","volume":"75","author":"Nagasaki","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0005-2760(81)90055-2","article-title":"An optimized method for measuring lecithin: cholesterol acyltransferase activity, independent of the concentration and quality of the physiological substrate","volume":"664","author":"Bartholome","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0022-2275(20)30175-9","article-title":"A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measure human lecithin-cholesterol acyltransferase","volume":"43","author":"Kobori","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0009-9120(03)00117-6","article-title":"Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula","volume":"36","author":"Sniderman","year":"2003","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jjcc.2019.08.011","article-title":"Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: a 6-month randomized trial","volume":"75","author":"Tani","year":"2020","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.5551\/jat.18002","article-title":"Eicosapentaenoic acid (EPA) reduces cardiovascular events: relationship with the EPA\/arachidonic acid ratio","volume":"20","author":"Ohnishi","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12944-018-0706-8","article-title":"N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study","volume":"17","author":"Ide","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0135","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.113.002731","article-title":"Omega-3 fatty acid blood levels: clinical significance and controversy","volume":"128","author":"Superko","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jjcc.2013.06.018","article-title":"Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size","volume":"63","author":"Tani","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40256-017-0238-z","article-title":"The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy","volume":"17","author":"Tani","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"issue":"Suppl.","key":"10.1016\/j.jjcc.2020.06.006_bib0150","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0021-9150(97)00312-2","article-title":"Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes","volume":"137","author":"Phillips","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0155","first-page":"387","article-title":"Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL\/HDL cholesterol ratio","volume":"47","author":"Dobi\u00e1sov\u00e1","year":"1998","journal-title":"Physiol Res"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.ATV.11.1.64","article-title":"Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease","volume":"11","author":"Dobiasova","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00380-017-1082-4","article-title":"A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity","volume":"33","author":"Tani","year":"2018","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11745-001-0735-3","article-title":"Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells","volume":"36","author":"Hirano","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0175","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2337\/dc06-1179","article-title":"Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome","volume":"30","author":"Satoh","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0180","first-page":"256","article-title":"Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia","volume":"62","author":"Nozaki","year":"1992","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0185","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jnutbio.2014.02.008","article-title":"Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene","volume":"25","author":"Raposo","year":"2014","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jjcc.2020.06.006_bib0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.metabol.2003.09.007","article-title":"An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia","volume":"53","author":"Calabresi","year":"2004","journal-title":"Metabolism"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720301854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508720301854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:03:05Z","timestamp":1760274185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508720301854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0914508720301854"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.06.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}